Evidence map›Paper›PMID 26022536›Full record

ArticleCirculation. Cardiovascular interventions2015

Fully percutaneous transthoracic left atrial entry and closure as a potential access route for transcatheter mitral valve interventions.

Toby Rogers, Kanishka Ratnayaka, William H Schenke, Merdim Sonmez, Ozgur Kocaturk, Jonathan R Mazal, Marcus Y Chen, Moshe Y Flugelman, James F Troendle, Anthony Z Faranesh and 1 more

Open access · greenAbstract read
In one paragraph

Article in Circulation. Cardiovascular interventions, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Improved passive catheter tracking with positive contrast for CMR-guided cardiac catheterization using partial saturation (pSAT).Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Toby RogersFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Kanishka RatnayakaFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
William H SchenkeFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Merdim SonmezFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Ozgur KocaturkFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Jonathan R MazalFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Marcus Y ChenFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Moshe Y FlugelmanFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
James F TroendleFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Anthony Z FaraneshFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.).
Robert J LedermanFrom the Cardiovascular and Pulmonary Branch, Division of Intramural Research (T.R., K.R., W.H.S., M.S., O.K., J.R.M., M.Y.C., A.Z.F., R.J.L.) and Office of Biostatistics Research, Division of Cardiovascular Sciences (J.F.T.), National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; Department of Cardiology, Children's National Medical Center, Washington DC (K.R.); Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey (O.K.); and Department of Cardiology, Carmel Medical Center, Haifa, Israel (M.Y.F.). lederman@nih.gov.
Boğaziçi University · TRChildren's National · US

Funding

NHLBI Animal Program DivisionZIGHL006020 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CLARK, TANNIA · 2009 to 2025
$47.3M
Novel catheter treatment of valve diseaseZIAHL006040 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEDERMAN, ROBERT J · 2010 to 2025
$23.6M
Real-time MRI guided cardiovascular interventionZIAHL005062 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEDERMAN, ROBERT J · 2009 to 2025
$21.6M
MRI catheter design and fabricationZIAHL006041 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEDERMAN, ROBERT J · 2014 to 2025
$12.2M
Therapies enabled-cardiovascular interventional MRIZ01HL005062 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEDERMAN, ROBERT J · 2003 to 2008
$6.0M
Intramural NIH HHS Z01 HL005062Intramural NIH HHS ZIA HL005062Intramural NIH HHS ZIA HL006040NHLBI NIH HHS Z01-HL006040
6 · The paper itself

Abstract

backgroundPercutaneous access for mitral interventions is currently limited to transapical and transseptal routes, both of which have shortcomings. We hypothesized that the left atrium could be accessed directly through the posterior chest wall under imaging guidance. METHODS AND

resultsWe tested percutaneous transthoracic left atrial access in 12 animals (10 pigs and 2 sheep) under real-time magnetic resonance imaging or x-ray fluoroscopy plus C-arm computed tomographic guidance. The pleural space was insufflated with CO2 to displace the lung, an 18F sheath was delivered to the left atrium, and the left atrial port was closed using an off-the-shelf nitinol cardiac occluder. Animals were survived for a minimum of 7 days. The left atrial was accessed, and the port was closed successfully in 12/12 animals. There was no procedural mortality and only 1 hemodynamically insignificant pericardial effusion was observed at follow-up. We also successfully performed the procedure on 3 human cadavers. A simulated trajectory to the left atrium was present in all of 10 human cardiac computed tomographic angiograms analyzed.

conclusionsPercutaneous transthoracic left atrial access is feasible without instrumenting the left ventricular myocardium. In our experience, magnetic resonance imaging offers superb visualization of anatomic structures with the ability to monitor and address complications in real-time, although x-ray guidance seems feasible. Clinical translation seems realistic based on human cardiac computed tomographic analysis and cadaver testing. This technique could provide a direct nonsurgical access route for future transcatheter mitral implantation.

Indexed as

AgedAnimalsFemaleHeart AtriaHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedMitral ValvePercutaneous Coronary InterventionSheepSwineTomography, X-Ray Computedcatheterizationendovascular proceduresheart valve prosthesis implantationmagnetic resonance imaging, interventionalmitral valve

Identifiers

PMID26022536
PMCPMC4537529
OpenAlexW1902688369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.